Research Archive — Page 43 of 134
-
April 20, 2023
Genetics and chronic pain
Polygenic risk scores — scores that reflect the influence of common genetic variants — could be used to predict the likelihood of developing chronic overlapping pain conditions and guide biomarker and targeted prevention efforts. -
April 20, 2023
Study details RNA editing in virus-infected cancer cells
Vanderbilt researchers detail the landscape of RNA editing — a form of RNA modification — in primary effusion lymphoma cells during Kaposi’s sarcoma-associated herpesvirus infection and identify an edited viral microRNA that is critical for infection. -
April 20, 2023
Malin receives a Vanderbilt distinguished service award
Bradley Malin, PhD, has received one of Vanderbilt University’s top honors, the Alexander Heard Distinguished Service Professor Award. -
April 20, 2023
Pharmacology research symposium set for April 28
Researchers from as far away as Brisbane, Australia, and Bangkok, Thailand, will participate in a scientific symposium at Vanderbilt University Medical Center on April 28 honoring the memory of the late Al Reynolds, PhD, professor of Pharmacology, emeritus, who died last year. -
April 19, 2023
Four elected to the American Academy of Arts & Sciences
Four Vanderbilt University faculty members were recently elected to the American Academy of Arts & Sciences. -
April 13, 2023
Low-professionalism residents later draw higher patient complaints: study
A Vanderbilt study finds a strong association between lower ratings for interpersonal communication skills among medical residents in their last year of training and greater likelihood of unsolicited patient complaints among doctors during their first year of employment after training. -
April 12, 2023
Research identifies new target that may prevent blood cancer
An international coalition of biomedical researchers co-led by Vanderbilt's Alexander Bick, MD, PhD, has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients’ risk of blood cancer.